Viral vectors in gene therapy: Where do we stand in 2023?
K Lundstrom - Viruses, 2023 - mdpi.com
Viral vectors have been used for a broad spectrum of gene therapy for both acute and
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …
Twenty‐five years of research about adipogenic adenoviruses: A systematic review
Infectious etiology is implicated in chronic diseases such as gastric ulcer or atherosclerosis.
However,“infection” is a recent term in the field of obesity. Since the first report in 1982 of …
However,“infection” is a recent term in the field of obesity. Since the first report in 1982 of …
Gene therapy cargoes based on viral vector delivery
K Lundstrom - Current Gene Therapy, 2023 - benthamdirect.com
Viral vectors have been proven useful in a broad spectrum of gene therapy applications due
to their possibility to accommodate foreign genetic material for both local and systemic …
to their possibility to accommodate foreign genetic material for both local and systemic …
Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K/Akt/FoxO1/PPARγ signaling pathway
Y Jiao, X Liang, J Hou, Y Aisa, H Wu, Z Zhang… - Lipids in Health and …, 2019 - Springer
Background This study aims to investigate the molecular mechanism of Adenovirus type 36
(Ad36) in adipocyte differentiation and glucolipid metabolism. Methods Rat obesity model …
(Ad36) in adipocyte differentiation and glucolipid metabolism. Methods Rat obesity model …
[HTML][HTML] E4orf1: The triple agent of adenovirus–Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy
L Göttig, S Schreiner - Tumour Virus Research, 2024 - Elsevier
Abstract Human Adenoviruses (HAdV) are nearly ubiquitous pathogens comprising
numerous sub-types that infect various tissues and organs. Among many encoded proteins …
numerous sub-types that infect various tissues and organs. Among many encoded proteins …
Hyperinsulinemia or insulin resistance: What impacts the progression of Alzheimer's disease?
V Hegde, NV Dhurandhar… - Journal of Alzheimer's …, 2019 - content.iospress.com
Type 2 diabetes mellitus (T2D), which is often accompanied by hyperinsulinemia and insulin
resistance, is associated with an increased risk for developing mild cognitive impairment …
resistance, is associated with an increased risk for developing mild cognitive impairment …
E4orf1: a protein for enhancing glucose uptake despite impaired proximal insulin signaling
Background Type 2 diabetes is often linked with impaired proximal insulin signaling. Hence,
a therapeutic agent that enhances cellular glucose uptake without requiring proximal insulin …
a therapeutic agent that enhances cellular glucose uptake without requiring proximal insulin …
E4orf1 enhances glucose uptake independent of proximal insulin signaling
Impaired proximal insulin signaling is often present in diabetes. Hence, approaches to
enhance glucose disposal independent of proximal insulin signaling are desirable …
enhance glucose disposal independent of proximal insulin signaling are desirable …
Reducing endogenous insulin is linked with protection against hepatic steatosis in mice
Background Obesity and type 2 diabetes (T2D) are closely associated with hepatic steatosis
(HS), which if untreated can advance to serious liver conditions. Since insulin promotes …
(HS), which if untreated can advance to serious liver conditions. Since insulin promotes …
Nanoparticle-mediated in vitro delivery of E4orf1 to preadipocytes is a clinically relevant delivery system to improve glucose uptake
Objective Impaired glycemic control is a common comorbidity of obesity. E4orf1 (E4), an
adenovirus-derived protein, reduces the activity of insulin receptor substrate (IRS), yet …
adenovirus-derived protein, reduces the activity of insulin receptor substrate (IRS), yet …